Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Neutropenia and KIT[original query] |
---|
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Oncology 2009 Mar 76 (5): 5. Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK |
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients. Investigational new drugs 2012 Apr 30 (2): 819-27. Yoon Dok Hyun, Ryu Min-Hee, Ryoo Baek-Yeol, Beck Moyeol, Choi Dae Ro, Cho Yoojin, Lee Jae-Lyun, Chang Heung-Moon, Kim Tae Won, Kang Yoon-K |
The frequencies of human neutrophil alloantigens among the Japanese population. Tissue antigens 2012 Jul 9999 (9999): 9999. Matsuhashi M, Tsuno NH, Kawabata M, Mishima Y, Okochi N, Santoso S, Tozuka M, Takahashi K |
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. PloS one 2014 9 (1): e85362. Damaj Gandhi, Joris Magalie, Chandesris Olivia, Hanssens Katia, Soucie Erinn, Canioni Danielle, Kolb Brigitte, Durieu Isabelle, Gyan Emanuel, Livideanu Cristina, Chèze Stephane, Diouf Momar, Garidi Reda, Georgin-Lavialle Sophie, Asnafi Vahid, Lhermitte Ludovic, Lavigne Christian, Launay David, Arock Michel, Lortholary Olivier, Dubreuil Patrice, Hermine Olivi |
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study. Journal of cancer research and clinical oncology 2015 Nov 141 (11): 2047-60. Hochhaus Andreas, Baccarani Michele, Giles Francis J, le Coutre Philipp D, Müller Martin C, Reiter Andreas, Santanastasio Helene, Leung Mimi, Novick Steven, Kantarjian Hagop |
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. The New England journal of medicine 2016 Jun 374 (26): 2530-41. Gotlib Jason, Kluin-Nelemans Hanneke C, George Tracy I, Akin Cem, Sotlar Karl, Hermine Olivier, Awan Farrukh T, Hexner Elizabeth, Mauro Michael J, Sternberg David W, Villeneuve Matthieu, Huntsman Labed Alice, Stanek Eric J, Hartmann Karin, Horny Hans-Peter, Valent Peter, Reiter Andre |
Human Neutrophil Alloantigen Genotype Frequencies Among Syrian Population. Clinical laboratory 2018 5 64 (4): 597-601. Hauck-Dlimi Barbara, Damrah Mohammed, Achenbach Susanne, Ott Stephan, Zimmermann Robert, Zingsem Juergen, Strobel Juli |
Antibodies to human neutrophil antigen HNA-3b implicated in cases of neonatal alloimmune neutropenia. Transfusion 2018 2 58 (5): 1264-1270. Lopes Larissa Barbosa, Abbas Samira Ali, Moritz Elyse, Martins Juliana Oliveira, Chiba Akemi Kuroda, Langhi Dante Mário, Bordin José |
Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Cancer medicine 2019 Dec . Grenda Anna, B?ach Justyna, Szczyrek Micha?, Krawczyk Pawe?, Nico? Marcin, Ku?nar Kami?ska Barbara, Jakimiec Monika, Balicka Gra?yna, Chmielewska Izabela, Batura-Gabryel Halina, Sawicki Marek, Milanowski Janu |
Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients. Archives of medical science : AMS 2021 3 17 (2): 474-480. Nico? Marcin, Rolska-Kopi?ska Anna, Krawczyk Pawe?, Grenda Anna, Bo?yk Aleksandra, Szczyrek Micha?, Milanowski Janu |
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases. American journal of hematology 2022 2 97 (5): 630-637. Singh Amritpal, Al-Kali Aref, Begna Kebede H, Litzow Mark R, Larsen Jeremy T, Sher Taimur, Abdelmagid Maymona G, Farrukh Faiqa, Reichard Kaaren K, Gangat Naseema, Pardanani Animesh, Tefferi Ayal |
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. Annals of hematology 2024 5 . Qingwei Wang, Yixin Hu, Li Gao, Senlin Zhang, Jun Lu, Bohan Li, Jie Li, Yanhua Yao, Shengqin Cheng, Peifang Xiao, Shaoyan |
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment. Journal of translational medicine 2024 4 22 (1): 379. Alessandro Ottaiano, Mariachiara Santorsola, Monica Ianniello, Anna Ceccarelli, Marika Casillo, Francesco Sabbatino, Nadia Petrillo, Marco Cascella, Francesco Caraglia, Carmine Picone, Francesco Perri, Roberto Sirica, Silvia Zappavigna, Guglielmo Nasti, Giovanni Savarese, Michele Caragl |
- Page last reviewed:Feb 1, 2024
- Content source: